Clinicopathological features | n | miR-34a | P value | |
---|---|---|---|---|
Low | High | |||
Age (yr) | Â | Â | Â | 0.695 |
<60 | 14 | 4 | 10 | Â |
≥60 | 13 | 5 | 8 |  |
Gender | Â | Â | Â | 1.000 |
Male | 16 | 8 | 8 | Â |
Female | 11 | 6 | 5 | Â |
Tumor size (cm) | Â | Â | Â | 0.449 |
<2 | 12 | 5 | 7 | Â |
≥2 | 15 | 9 | 6 |  |
Pathological type | Â | Â | Â | 0.222 |
Adenocarcinoma | 24 | 11 | 13 | Â |
Mucocellulare carcinoma | 0 | 0 | 0 | Â |
Adenosquamous carcinoma | 3 | 3 | 0 | Â |
Squamous carcinoma | 0 | 0 | 0 | Â |
Undifferentiated carcinoma | 0 | 0 | 0 | Â |
Cell differentiation | Â | Â | Â | 0.326 |
Well | 4 | 3 | 1 | Â |
Moderately | 8 | 5 | 3 | Â |
Poorly | 15 | 8 | 7 | Â |
Bismuth classification | Â | Â | Â | 0.385 |
Bismuth I | 7 | 1 | 6 | Â |
Bismuth II | 13 | 10 | 3 | Â |
Bismuth III | 6 | 2 | 4 | Â |
Bismuth IV | 1 | 1 | 0 | Â |
Lymphatic node metastasis | Â | Â | Â | 0.004 |
Absent | 9 | 1 | 8 | Â |
Present | 18 | 13 | 5 | Â |
Clinical stages | Â | Â | Â | <0.001 |
I + II | 13 | 2 | 11 |  |
III + IV | 14 | 12 | 2 |  |